# A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis

> **NCT02950155** · PHASE3 · COMPLETED · sponsor: **Fredrik Piehl** · enrollment: 47 (actual)

## Conditions studied

- Generalized Myasthenia Gravis

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Sodium Chloride solution

## Key facts

- **NCT ID:** NCT02950155
- **Lead sponsor:** Fredrik Piehl
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-16
- **Primary completion:** 2021-01-30
- **Final completion:** 2022-01-31
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950155, "A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02950155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*